Christelle Johnson
Company: Personalis Inc
Seminars:
2:30 pm ImmunoID NeXT: A Comprehensive Platform for Immuno- Oncology – Improving Neoantigen Prediction, Evaluating Tumor Dynamics, and Immunogenomics Profiling
Seminar_day: Day One